Tom Johnson
Founder & CEO @ Breyer Capital
Menlo Park, United States
Tom Johnson is a Series B investor at Breyer Capital in Menlo Park focused on Artificial Intelligence and Software. Jim Breyer is based out of Austin, Texas, and is the Founder & CEO of Breyer Capital. Jim previously worked at IDG Capital as Co-Chairman. Jim Breyer attended Harvard Business School.
- Total investments:
- 105
- Last investment:
- Lead investor:
- 31%
Last updated:
For AI agents: llms.txt
Industries Tom Johnson invests in
Stages Tom Johnson invests in
Countries Tom Johnson invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $6M–$150M
- Series A
- $7.5M–$30M
- Series B
- $13M–$80M
Investment Focus
Industry
- Artificial Intelligence 16 (15%)
- Software 13 (12%)
- Health Care 13 (12%)
- Information Technology 12 (11%)
- Financial Services 8 (8%)
Stage
- Series B 22 (21%)
- Series A 19 (18%)
- Seed 14 (13%)
- Series C 10 (10%)
- Funding Round 8 (8%)
Country
- United States 50 (48%)
- United Kingdom 3 (3%)
- Singapore 2 (2%)
- Egypt 1 (1%)
- Ghana 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Circuit offers a platform for feature extraction to streamline data preparation for AI and machine learning. | $30M / Series A / Jun 17, 2026 | ||
| Catena Labs incubate independent products spanning identity, communications, AI, and commerce. The company's mission is to empower people with agency, safety, value, and joy online. | $30M / Series A / May 20, 2026 | ||
| Advanced Machine Intelligence develops artificial intelligence systems that model real-world environments using sensor data. The organization focuses on building machine learning architectures that form abstract representations of physical and digital environments, allowing systems to reason, predict outcomes, and plan sequences of actions. Itsresearch includes world models that process continuous and complex data while filtering unpredictable elements to support structured decision making. The technology is designed to enable AI agents to evaluate the consequences of actions and operate under defined safety and control mechanisms. Advanced Machine Intelligence collaborates with industry and research communities to explore applications of these systems in areas such as industrial automation, robotics, wearable technology, and healthcare. The company also publishes research and develops software frameworks that support experimentation, deployment, and evaluation of intelligent systems. | $1B / Seed / Mar 10, 2026 | ||
| Circuit offers a platform for feature extraction to streamline data preparation for AI and machine learning. | $30M / Feb 17, 2026 | ||
| Healthcare from home. Access online doctors and treatments anytime, anywhere. | Seed / Jun 07, 2025 | ||
| Catena Labs incubate independent products spanning identity, communications, AI, and commerce. The company's mission is to empower people with agency, safety, value, and joy online. | $18M / Seed / May 20, 2025 | ||
| SandboxAQ develops quantitative artificial intelligence technologies that combine AI methods with physics-based modeling and advanced computational techniques to address scientific and industrial challenges. Its Large Quantitative Models (LQMs) are designed to analyze complex quantitative data and support applications in areas such as drugdiscovery, chemicals and materials research, cybersecurity, navigation, and sensing. The company provides software and simulation tools that help organizations study molecular interactions, manage cryptographic systems, and operate in environments where conventional positioning technologies may be unreliable. SandboxAQ also works with experimental and proprietary scientific datasets to generate predictions and insights for research and engineering workflows. Its technologies are used across industries including life sciences, energy, defense, and manufacturing. | $150M / Series E / Apr 04, 2025 | ||
| Network Bio is a clinical and molecular data library enabling precision medicine approaches for common human diseases. Its platform delivers a centralized repository for clinical and molecular data that allows researchers to identify patterns and correlations that can be used to develop new treatments and diagnostic tools. | $17M / Seed / Feb 27, 2025 | ||
| Taager is a social e-commerce platform enabling online merchants with end-to-end logistics. | $6.8M / Series B / Feb 11, 2025 | ||
| SandboxAQ develops quantitative artificial intelligence technologies that combine AI methods with physics-based modeling and advanced computational techniques to address scientific and industrial challenges. Its Large Quantitative Models (LQMs) are designed to analyze complex quantitative data and support applications in areas such as drugdiscovery, chemicals and materials research, cybersecurity, navigation, and sensing. The company provides software and simulation tools that help organizations study molecular interactions, manage cryptographic systems, and operate in environments where conventional positioning technologies may be unreliable. SandboxAQ also works with experimental and proprietary scientific datasets to generate predictions and insights for research and engineering workflows. Its technologies are used across industries including life sciences, energy, defense, and manufacturing. | $300M / Series E / Dec 18, 2024 | ||
| See all 105 investments → | |||
Co-Investors
About Breyer Capital
Breyer Capital is a premier global venture capital and private equity investor focused on catalyzing high-impact entrepreneurs in the United States and China. Founded by Jim Breyer in 2006, Breyer Capital makes long-term, idea-driven strategic investments in its chosen core areas: social media, entertainment/media, digital health, and financial technologies. Breyer Capital actively partners with a diverse set of companies including early-stage startups building breakthrough technologies, fast growing companies, and established worldwide leading corporations. Its team enjoys helping to frame strategic investments anchored by the passion of founders and owner/operator teams, the insights of its network of world-class investors, and a conviction that artificial intelligence, machine learning, and virtual reality will transform technology and investment opportunities globally.
Breyer Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Daniel Breyer
Investor
|
|||
|
Tom Johnson
Founder & CEO
|
|||
Leo Grady
CEO in Residence
|
|||
Morgan Cheatham
Head of health care and life sciences
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Tom Johnson invest in?
Tom Johnson invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Series B and Series A stage. Most of the 105 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Tom Johnson invest in?
Tom Johnson typically joins rounds of $6M–$150M at Seed, $7.5M–$30M at Series A and $13M–$80M at Series B. These are whole funding-round sizes, not Tom Johnson's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Tom Johnson took part in.
How do I contact Tom Johnson?
Public channels for Tom Johnson include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Tom Johnson last invest?
The most recent investment recorded for Tom Johnson closed in Jun 2026. Shizune tracks 105 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
